VIRxSYS completes HIV gene therapy study
VIRxSYS has announced the completion of the phase I study of its novel HIV gene therapy, which has been touted as the first of a next-generation anti-HIV treatment involving gene therapy. The positive results mean a phase II study will be initiated.